Eyileten, C.; Postula, M.; Jakubik, D.; Toma, A.; Mirowska-Guzel, D.; Patti, G.; Renda, G.; Siller-Matula, J.M.
Non-Vitamin K Oral Anticoagulants (NOAC) versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type. J. Clin. Med. 2020, 9, 1120.
https://doi.org/10.3390/jcm9041120
AMA Style
Eyileten C, Postula M, Jakubik D, Toma A, Mirowska-Guzel D, Patti G, Renda G, Siller-Matula JM.
Non-Vitamin K Oral Anticoagulants (NOAC) versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type. Journal of Clinical Medicine. 2020; 9(4):1120.
https://doi.org/10.3390/jcm9041120
Chicago/Turabian Style
Eyileten, Ceren, Marek Postula, Daniel Jakubik, Aurel Toma, Dagmara Mirowska-Guzel, Giuseppe Patti, Giulia Renda, and Jolanta M. Siller-Matula.
2020. "Non-Vitamin K Oral Anticoagulants (NOAC) versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type" Journal of Clinical Medicine 9, no. 4: 1120.
https://doi.org/10.3390/jcm9041120
APA Style
Eyileten, C., Postula, M., Jakubik, D., Toma, A., Mirowska-Guzel, D., Patti, G., Renda, G., & Siller-Matula, J. M.
(2020). Non-Vitamin K Oral Anticoagulants (NOAC) versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type. Journal of Clinical Medicine, 9(4), 1120.
https://doi.org/10.3390/jcm9041120